Hydrogen Sulfide Delivery to Enhance Bone Tissue Engineering Cell Survival

Soheila Ali Akbari Ghavimi,Trent J. Faulkner,Rama Rao Tata,August J. Hemmerla,Samantha E. Huddleston,Farnoushsadat Rezaei,Ethan S. Lungren,Rui Zhang,Erin E. Bumann,Bret D. Ulery
DOI: https://doi.org/10.3390/ph17050585
IF: 4.6
2024-05-03
Pharmaceuticals
Abstract:Though crucial for natural bone healing, local calcium ion (Ca2+) and phosphate ion (Pi) concentrations can exceed the cytotoxic limit leading to mitochondrial overload, oxidative stress, and cell death. For bone tissue engineering applications, H2S can be employed as a cytoprotective molecule to enhance mesenchymal stem cell (MSC) tolerance to cytotoxic Ca2+/Pi concentrations. Varied concentrations of sodium hydrogen sulfide (NaSH), a fast-releasing H2S donor, were applied to assess the influence of H2S on MSC proliferation. The results suggested a toxicity limit of 4 mM for NaSH and that 1 mM of NaSH could improve cell proliferation and differentiation in the presence of cytotoxic levels of Ca2+ (32 mM) and/or Pi (16 mM). To controllably deliver H2S over time, a novel donor molecule (thioglutamic acid—GluSH) was synthesized and evaluated for its H2S release profile. Excitingly, GluSH successfully maintained cytoprotective level of H2S over 7 days. Furthermore, MSCs exposed to cytotoxic Ca2+/Pi concentrations in the presence of GluSH were able to thrive and differentiate into osteoblasts. These findings suggest that the incorporation of a sustained H2S donor such as GluSH into CaP-based bone graft substitutes can facilitate considerable cytoprotection, making it an attractive option for complex bone regenerative engineering applications.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?